(66444-1-Ig)
用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| Positive WB detected in | Calyculin A treated PC-3 cells, Calyculin A treated HEK-293T cells, HSC-T6 cells, TPA treated Jurkat cells, Calyculin A treated HSC-T6 cells |
| Positive IHC detected in | human breast cancer tissue, Calyculin A treated Jurkat cells, human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | Calyculin A treated HeLa cells |
| Positive FC (Intra) detected in | Calyculin A treated PC-3 cells |
推荐稀释比例
- Western Blot (WB)1:2000-1:10000
- Immunohistochemistry (IHC)1:100-1:400
- Immunofluorescence (IF)/ICC1:200-1:800
- Flow Cytometry (FC) (INTRA)0.50 ug per 10^6 cells in a 100 µl suspension
推荐稀释说明
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. Sample-dependent, Check data in validation data gallery.
详细信息
背景信息
1) What is AKT? The serine/threonine kinase B AKT pathway (also known as the PI3K-Akt pathway) plays a vital role in the regulation of cellular processes, including cell proliferation, survival, and growth - processes that are essential for oncogenesis. Mutation of the regulator proteins PI3K and PTEN causes uncontrolled disruption within the PI3-kinase pathway, leading to the development of human cancers (1,2; see also AKT pathway poster for more details). 2) phospho-AKT and FAQs A) What is the best way to normalize phosphorylated proteins analyzed by western blot? Normalize phospho-AKT and total AKT with your loading control (e.g. Actin, tubulin), then calculate the phospho/total ratio using these normalized values. Put more simply 1. Calculate the ratio of band intensities of a phospho-AKT band: the loading control. 2. Calculate the ratio of band intensities of total AKT: loading control. 3. Divide ratio obtained #1 by #2 to obtain a normalized value for comparison among different conditions. This procedure allows one to distinguish between a change in AKT expression and a change in the ratio of phospho-AKT. * If you are looking at the differences in a phospho-AKT expression resulting from an experimental condition (e.g., knockdown), you should also show the expression of total AKT to distinguish between a change in AKT expression (transcription/translation level) and a change in the AKT phosphorylation status. B) What is the observed molecular weight for AKT and phospho-AKT? Molecular Weight AKT - 56 kDa Molecular Weight phospho-AKT - 60 kDa (Figure 1) Figure 1. WB: HEK-293 cell lysate was subjected to SDS PAGE followed by western blot with 60203-2-Ig (AKT antibody) and 66444-1-Ig (AKT-phospho-S473 antibody) at a dilution of 1:4000 incubated at room temperature for 1.5 hours. C) Are there any special WB conditions to optimize staining of a phospho-AKT? Since this is a phosphorylated protein, 5% BSA is recommended over non-fat milk as a blocking agent. D) What are good positive and negative controls for a phospho-AKT? - Positive Control: HEK293 cells - Negative Control: Treatment with PI3K inhibitors (e.g. wortmannin) E) What species does this antibody react with? Our internal testing has confirmed that it reacts with the human and mouse forms of phospho-AKT.Reactivity with the human form is also supported by the literature's citations of this antibody . References 1. Perturbations of the AKT signaling pathway in human cancer. 2. Targeting the PI3K-Akt pathway in human cancer: rationale and promise.
文献引用 (375)
Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells
具有新型胞内模块的嵌合抗原受体可提高T细胞的抗肿瘤活性
Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma.
靶向 AKT 是治疗 SOX2 阳性、化疗耐药性骨肉瘤的一种有前景的策略
Accumulation of Damaging Lipids in the Arf1-Ablated Neurons Promotes Neurodegeneration through Releasing mtDNA and Activating Inflammatory Pathways in Microglia.
Arf1 缺失神经元中有害脂质的积累通过释放 mtDNA 和激活小胶质细胞中的炎症通路促进神经退行性变
C1q(+) Macrophage-Tumor Cell Interaction Promoted Tumorigenesis via GPR17/PI3K/AKT Pathway Induced DNA Hypermethylation in Nasopharyngeal Carcinoma.
C1q(+)巨噬细胞-肿瘤细胞相互作用通过GPR17/PI3K/AKT通路诱导鼻咽癌DNA高甲基化促进肿瘤发生
Nanodelivery of Y-27632 by RGD-modified liposome enhances radioimmunotherapy of hepatocellular carcinoma via tumor microenvironment matrix stiffness reprogramming.
通过RGD修饰的脂质体纳米递送Y-27632,通过肿瘤微环境基质硬度重编程增强肝细胞癌的放射免疫疗法
Targeting PSMD14 combined with arachidonic acid induces synthetic lethality via FADS1 m6A modification in triple-negative breast cancer
靶向PSMD14联合花生四烯酸可通过FADS1 m6A修饰诱导三阴性乳腺癌的合成致死效应
Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis.
曲克芦丁通过 CD155/SRC/β-catenin 信号轴抑制骨肉瘤的干性
Sustained release of miR-21 carried by mesenchymal stem cell-derived exosomes from GelMA microspheres inhibits ovarian granulosa cell apoptosis in premature ovarian insufficiency.
GelMA微球中间充质干细胞来源的外泌体持续释放miR-21,可抑制卵巢早衰中卵巢颗粒细胞的凋亡
Synergistic exacerbation of periprosthetic osteolysis by inflammatory bowel disease and titanium ions: Impaired osteogenesis of BMSCs via PI3K/AKT signaling.
炎症性肠病和钛离子协同加剧假体周围骨溶解:通过 PI3K/AKT 信号通路损害 BMSC 的成骨作用
Matrix stiffness regulates glucose-6-phosphate dehydrogenase expression to mediate sorafenib resistance in hepatocellular carcinoma through the ITGB1-PI3K/AKT pathway.
基质硬度通过 ITGB1-PI3K/AKT 通路调节葡萄糖-6-磷酸脱氢酶的表达,从而介导肝细胞癌的索拉非尼耐药性
- 1
- 2
- 3
- 4
- 5
- 6
- 38